Clinical trial

A Study to Compare Two Different Anti-HIV Drug Regimens

NCT00000924

StatusCOMPLETED

Study typeINTERVENTIONAL

Start dateUnknown

PhasePHASE2

Study timeline

Registry last updated2021-10-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

RitonavirDRUG · verified · RxNorm: ritonavir

Nelfinavir mesylateDRUG · verified · RxNorm: nelfinavir mesylate

NevirapineDRUG · verified · RxNorm: nevirapine

StavudineDRUG · verified · RxNorm: stavudine

DidanosineDRUG · verified · RxNorm: didanosine

Sponsors & collaborators

National Institute of Allergy and Infectious Diseases (NIAID)lead sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)collaborator

Mapped research locations

New YorkNew York, United States5 ChicagoIllinois, United States3 Los AngelesCalifornia, United States2 BaltimoreMaryland, United States2 The BronxNew York, United States2 New OrleansLouisiana, United States2 San JuanPuerto Rico2 NewarkNew Jersey, United States2 BostonMassachusetts, United States1 DallasTexas, United States1 AtlantaGeorgia, United States1 MiamiFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00000924 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.